Seeing Is Believing
ALLO is currently covered by 16 analysts with an average price target of $15.96. This is a potential upside of $12.92 (425%) from yesterday's end of day stock price of $3.04.
Allogene Therapeutics's activity chart (see below) currently has 93 price targets and 107 ratings on display. The stock rating distribution of ALLO is 80.95% BUY, 16.67% HOLD and 2.38% SELL.
Analysts average stock forecasts to be materialized ratio is 25.8% with an average time for these price targets to be met of 80.79 days.
Highest price target for ALLO is $10, Lowest price target is $5, average price target is $15.96.
Most recent stock forecast was given by BRIAN CHENG from JPMORGAN on 27-Feb-2024. First documented stock forecast 05-Nov-2018.
Currently out of the existing stock ratings of ALLO, 34 are a BUY (80.95%), 7 are a HOLD (16.67%), 1 are a SELL (2.38%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
8
$4.96 (163.16%)
9
1 months 30 days ago
0/3 (0%)
$2.86 (55.64%)
Buy
10
$6.96 (228.95%)
12
3 months 7 days ago
1/7 (14.29%)
$6.91 (223.62%)
28
Buy
10
$6.96 (228.95%)
12
3 months 7 days ago
0/5 (0%)
$6.91 (223.62%)
Buy
18
3 months 18 days ago
2/9 (22.22%)
$12.2 (210.34%)
94
Hold
35
3 months 21 days ago
1/2 (50%)
$19.71 (128.91%)
6
What is ALLO (Allogene Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on ALLO (Allogene Therapeutics) with a proven track record?
Which analyst has the most public recommendations on ALLO (Allogene Therapeutics)?
Which analyst is the currently most bullish on ALLO (Allogene Therapeutics)?
Which analyst is the currently most reserved on ALLO (Allogene Therapeutics)?